By Bhanvi Satija and Prerna Bedi July 10 (Reuters) - GSK said on Friday that partner Hansoh Pharmaceutical's experimental ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

A landmark Northwestern Medicine study published in JAMA suggests lung transplantation can significantly extend survival in ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

The nuclear medicine therapy targets prostate-specific membrane antigen (PSMA)-positive cancer cells, delivering radiation directly to tumours while limiting damage to healthy tissue—a shift toward ...

A urologist with 35 years of experience argues that eliminating out-of-pocket costs for high-risk men could save lives, just ...

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

Hope for men with high-risk non-metastatic hormone resistant prostate cancerBy Dr Jacqueline Schmitt - Manager, Research ...

What Is It, and Why Does It Matter? Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of ...